Toggle Side Panel
Close search

Sickle Cell Disease Community › Forums › Diagnosis​ Info ​and​ ​General​ ​Questions › Gene Editing Tool in Ongoing Sickle Cell Trial of BIVV003 Supported by Early Study

  • Diagnosis​ Info ​and​ ​General​ ​Questions

    Gene Editing Tool in Ongoing Sickle Cell Trial of BIVV003 Supported by Early Study

    Posted by MG Community Member on February 3, 2020 at 9:10 am

    A proof-of-concept study supports Sangamo’s ZFN gene editing technology used with the cell therapy BIVV003, now in a Phase 1/2 trial in severe SCD patients. Click here to learn more.

    What do you think of this news?

    MG Community Member replied 6 years, 1 month ago 0 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .